Literature DB >> 20719375

Levels of circulating IL-33 and eosinophil cationic protein in patients with hypereosinophilia or pulmonary eosinophilia.

Hak-Ryul Kim, Chang-Duk Jun, Young-Jin Lee, Sei-Hoon Yang, Eun-Taik Jeong, Seok-Don Park, Do-Sim Park.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20719375     DOI： 10.1016/j.jaci.2010.06.038

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  5 in total

1.  Possible Role of IL-25 in Eosinophilic Lung Inflammation in Patients with Chronic Eosinophilic Pneumonia.

Authors:  Shigeki Katoh; Masaki Ikeda; Nobuhiro Matsumoto; Hiroki Shimizu; Masaaki Abe; Yoshihiro Ohue; Keiji Mouri; Yoshihiro Kobashi; Masamitsu Nakazato; Mikio Oka
Journal:  Lung       Date:  2017-09-05       Impact factor: 2.584

2.  Interleukin-33 and ST2 Signaling in Tumor Microenvironment.

Authors:  Jaewoo Hong; Soohyun Kim; P Charles Lin
Journal:  J Interferon Cytokine Res       Date:  2018-09-25       Impact factor: 2.607

Review 3.  The role of interleukin-33 in rhinitis.

Authors:  Barbara Rogala; Joanna Glück
Journal:  Curr Allergy Asthma Rep       Date:  2013-04       Impact factor: 4.806

4.  Clinical and Biological Markers in Hypereosinophilic Syndromes.

Authors:  Paneez Khoury; Michelle Makiya; Amy D Klion
Journal:  Front Med (Lausanne)       Date:  2017-12-22

5.  In drug-induced, immune-mediated hepatitis, interleukin-33 reduces hepatitis and improves survival independently and as a consequence of FoxP3+ T-cell activity.

Authors:  Merylin Cottagiri; Maeva Nyandjo; Matthew Stephens; Joel J Mantilla; Hirohisa Saito; Ian R Mackay; Noel R Rose; Dolores B Njoku
Journal:  Cell Mol Immunol       Date:  2018-07-20       Impact factor: 11.530
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.